Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Parenteral and Enteral Nutrition
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Adams, S.
Right arrow Articles by Jensen, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adams, S.
Right arrow Articles by Jensen, G. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Changes in Plasma and Erythrocyte Fatty Acids in Patients Fed Enteral Formulas Containing Different Fats

Steve Adams, RPH

Department of Gastroenterology and Nutrition, Geisinger Medical Center, Danville, Pennsylvania, Nutrition Department, The Pennsylvania State University, University Park

Yu-Yan Yeh, PHD

Nutrition Department, The Pennsylvania State University, University Park

Gordon L. Jensen, MD, PHD

Department of Gastroenterology and Nutrition, Geisinger Medical Center, Danville, Pennsylvania, Nutrition Department, The Pennsylvania State University, University Park

Critically ill hospital patients were fed enteral formulas containing different fat substrates. Seven patients received formula X, which contained 28 g of structured triglycerides and menhaden oil to provide 7.6 g of medium-chain fatty acids, 2.5 g linoleic acid, 1.3 g eicosapentaenoic acid, and 0.4 g docosahexaenoic acid per 1000 mL of formula. Six patients received formula Y consisting of 36.8 g of medium-chain triglycerides and corn and soy oils providing 14.3 g medium-chain fatty acids and 11.7 g linoleic acid per 1000 mL. Feeding of formula X increased plasma total phospholipid levels of eicosapentaenoic acid on days 7 and 14 and docosahexaenoic acid levels on day 14. Plasma levels of linoleic acid were reduced in formula-X-fed in comparison to formula-Y-fed patients, whereas arachidonic acid was maintained in both groups during feeding. As a result of these changes, the patients receiving formula X had decreased ratios of arachidonic acid:eicosapentaenoic acid in plasma. Formula Y feeding did not alter eicosapentaenoic acid and docosahexaenoic acid levels in the plasma. In the erythrocyte, formula X feeding resulted in a threefold increase in eicosapentaenoic acid from mean baseline levels of 0.4 ± 0.4% to a mean value of 1.2 ± 0.9% at day 7. The formula X feeding decreased linoleic acid levels on days 7 and 14, whereas levels of arachidonic acid and docosahexaenoic acid remained constant. Formula Y feeding did not affect any of the parameters measured for erythrocytes. The ability to alter plasma and erythrocyte levels of n-3 fatty acids and plasma arachidonic acid:eicosapentaenoic acid ratios may have important implications for patients at risk for sepsis. (Journal of Parenteral and Enteral Nutrition 17:30-34, 1993)

Journal of Parenteral and Enteral Nutrition, Vol. 17, No. 1, 30-34 (1993)
DOI: 10.1177/014860719301700130


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
JPEN J Parenter Enteral NutrHome page
P. R. Schloerb
Immune-Enhancing Diets: Products, Components, and Their Rationales
JPEN J Parenter Enteral Nutr, March 1, 2001; 25(2_suppl): S3 - S7.
[PDF]


Home page
J. Nutr.Home page
J. M. Campbell, G. C. Fahey Jr., C. A. Lichtensteiger, S. J. Demichele, and K. A. Garleb
An Enteral Formula Containing Fish Oil, Indigestible Oligosaccharides, Gum Arabic and Antioxidants Affects Plasma and Colonic Phospholipid Fatty Acid and Prostaglandin Profiles in Pigs
J. Nutr., January 1, 1997; 127(1): 137 - 145.
[Abstract] [Full Text]


Home page
JPEN J Parenter Enteral NutrHome page
S. J. Bell, S. Chavali, B. R. Bistrian, C. A. Connolly, T. Utsunomiya, and R. A. Forse
Dietary Fish Oil and Cytokine and Eicosanoid Production During Human Immunodeficiency Virus Infection
JPEN J Parenter Enteral Nutr, January 1, 1996; 20(1): 43 - 49.
[Abstract] [PDF]